Lv31
208 积分 2025-04-26 加入
Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer
5个月前
已完结
Predictive Value of PIK3CA Mutations for Response to CDK4/6 Inhibitors in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
7个月前
已关闭
Estrogen receptor conversion in bone, liver and lung metastases from breast cancer
7个月前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
1年前
已完结
皖公网安备34019202002308
